Karl Munger is a Professor and the Interim Chair of the Department of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine in Boston, USA. Research in his group focuses on delineating the molecular mechanisms of human papillomavirus-associated cancer development. He earned a Ph.D. degree in Biochemistry from the University of Zurich, Switzerland. Subsequently, he trained as a postdoctoral fellow at the National Cancer Institute, National Institutes of Health in Bethesda, USA. He started his own research group at Harvard Medical School (Boston, USA) and moved to Tufts University School of Medicine in 2014. He has authored more than 200 primary research articles, reviews and book chapters and has been elected a fellow of the American Academy of Microbiology. His research is supported by grants from the National Institutes of Health. He has also received grant funding from the American Cancer Society and other agencies. He serves on the Editorial Boards of the Journal of Virology, Virology, Cancer Biology & Therapy, Cancers, Signal Transduction and Targeted Therapy, is a Section Editor for PLOS Pathogens and a Co-Editor-in-Chief of Current Research in Virological Science, a newly launched open access journal by Elsevier.